Effect of labetalol on continuous ambulatory blood pressure. 1979

V Balasubramanian, and S Mann, and E B Raftery, and M W Millar-Craig, and D Altman

1 The hypotensive action of labetalol was evaluated during 24 h by continuous intra-arterial ambulatory monitoring in 14 patients. The dose used ranged from 300--1800 mg daily. 2 The drug caused a significant reduction of systolic BP in 19 and diastolic BP in 20 of the 24 h of monitoring. Heart rate was also reduced but less markedly than BP. 3 The rapid early morning increase in BP was also effectively controlled. 4 The mild pre-waking increase in BP was not significantly reduced. 5 Labetalol treatment reduced the variation in systolic BP from the lowest observed quarter-hourly mean as compared with pre-treatment values. 6 The quarter hourly mean values were consistently smooth and revealed no sudden variations which might have resulted from postural hypotension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007741 Labetalol A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS. AH-5158,Albetol,Apo-Labetalol,Dilevalol,Labetalol Hydrochloride,Labetalol, (R,R)-Isomer,Labetolol,Normodyne,Presolol,R,R-Labetalol,SCH-19927,Trandate,AH 5158,AH5158,Apo Labetalol,ApoLabetalol,Hydrochloride, Labetalol,R,R Labetalol,SCH 19927,SCH19927
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D004983 Ethanolamines AMINO ALCOHOLS containing the ETHANOLAMINE; (-NH2CH2CHOH) group and its derivatives. Aminoethanols
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse

Related Publications

V Balasubramanian, and S Mann, and E B Raftery, and M W Millar-Craig, and D Altman
February 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation,
V Balasubramanian, and S Mann, and E B Raftery, and M W Millar-Craig, and D Altman
June 1992, Revista medica de Chile,
V Balasubramanian, and S Mann, and E B Raftery, and M W Millar-Craig, and D Altman
January 2000, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis,
V Balasubramanian, and S Mann, and E B Raftery, and M W Millar-Craig, and D Altman
August 2004, Blood pressure monitoring,
V Balasubramanian, and S Mann, and E B Raftery, and M W Millar-Craig, and D Altman
February 1995, The American journal of cardiology,
V Balasubramanian, and S Mann, and E B Raftery, and M W Millar-Craig, and D Altman
January 1982, Medical informatics = Medecine et informatique,
V Balasubramanian, and S Mann, and E B Raftery, and M W Millar-Craig, and D Altman
March 1995, American journal of hypertension,
V Balasubramanian, and S Mann, and E B Raftery, and M W Millar-Craig, and D Altman
January 1994, International journal of sports medicine,
V Balasubramanian, and S Mann, and E B Raftery, and M W Millar-Craig, and D Altman
November 2000, Alternative therapies in health and medicine,
V Balasubramanian, and S Mann, and E B Raftery, and M W Millar-Craig, and D Altman
August 1986, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!